Aphthous Ulcers (Aphthous Stomatitis)
BASICS
- Definition: Recurrent, painful, shallow ulcerations of the non-keratinized oral mucosa.
- Synonyms: Canker sores, aphthae, aphthous stomatitis.
- Natural history: Self-limited, with spontaneous resolution; recurrent in nature.
CLASSIFICATION
I. Clinical Categories
| Type | Description |
|---|---|
| Simple aphthosis | Episodic (<7 episodes/year), few ulcers, minimal pain, self-limited (1–2 weeks). |
| Complex aphthosis | Frequent/continuous ulcers, major pain, disability, may include genital aphthae, slow healing. |
II. Morphologic Subtypes
| Subtype | Features |
|---|---|
| Minor (Mikulicz aphthae) | <10 mm, 1–5 ulcers, age 5–19, heals in 4–14 days, no scarring. |
| Major (Sutton disease) | >10 mm, 1–10 ulcers, age 10–19, heals in weeks–months, may scar. |
| Herpetiform | 1–2 mm ulcers, cluster in 10s–100s, age 20–29, coalesce into large lesions, no HSV link. |
EPIDEMIOLOGY
- Most common oral mucosal ulcerative condition.
- Prevalence: 5–85% lifetime, varies by ethnicity and SES.
- More common in: <40 years, Caucasians, nonsmokers, higher SES.
ETIOLOGY & PATHOPHYSIOLOGY
- Multifactorial: Genetic predisposition, altered cell-mediated immunity, increased salivary cortisol (stress).
- HLA associations noted.
- No association with HSV in herpetiform ulcers.
RISK FACTORS
- Oral trauma (e.g. sharp teeth, dental procedures)
- Sodium lauryl sulfate (SLS) toothpaste
- Stress, anxiety
- Nutritional deficiencies: B12, iron, folate, zinc, vitamin D
- Immune deficiency
- Tobacco cessation
- Hormonal changes (e.g. menstruation)
- Associated infections: H. pylori
- Systemic diseases: celiac, IBD, Behçet syndrome
PREVENTION
- Avoid SLS-containing toothpaste
- Nutritional support: Vitamin B12, D, zinc
- Reduce oral trauma and stress
CLINICAL FEATURES
History
- Painful oral ulcerations exacerbated by speech, eating, acidic/hot/spicy foods
- Prodrome: burning/pruritus 2–48 hrs prior
- Age of onset: typically 5–29 years
- Recurrent pattern
Physical Exam
- Round/ovoid ulcer with gray-white base and erythematous halo
- Common sites: buccal/labial mucosa, ventral tongue, soft palate
- Evaluate for secondary infection: fever, lymphadenopathy, edema, pus
DIFFERENTIAL DIAGNOSIS
| Etiology | Distinctive Features |
|---|---|
| HSV | Vesicular, keratinized mucosa, systemic prodrome |
| HIV | Persistent, painful ulcers, advanced disease |
| Behçet syndrome | Genital + oral ulcers, uveitis, arthritis |
| IBD | Aphthae with GI symptoms (Crohn’s, UC) |
| SLE | Systemic features, autoimmunity |
| Celiac disease | Aphthae with malabsorption, dermatitis herpetiformis |
| Medication | Fixed drug eruptions, vancomycin-induced linear IgA |
| Malignancy | Persistent, nonhealing, leukoplakia, lymphadenopathy |
DIAGNOSTIC WORKUP
Initial Tests (if severe or recurrent)
- CBC (anemia), ferritin, folic acid, vitamin B12, zinc
- Consider biopsy and viral culture if nonhealing
- Autoimmune/rheumatologic panel for systemic suspicion
- GI referral if symptoms suggest IBD or celiac
TREATMENT
General Principles
- Primarily symptomatic management
- Goal: relieve pain, reduce recurrence, accelerate healing
FIRST-LINE
| Category | Agents | Notes |
|---|---|---|
| Topical corticosteroids | Triamcinolone 0.1% paste Fluocinonide 0.05% gel |
Apply 2–4× daily for ≤2 weeks |
| Topical anesthetics | Lidocaine 5% ointment or spray Hyaluronic acid 2.5% |
Symptomatic relief only |
| Antimicrobial mouth rinses | Chlorhexidine 0.12% or 0.2% Doxycycline rinses |
Chlorhexidine 3× daily; doxycycline 100 mg in 10 mL water, 4×/day for 3 days |
| Topical immunomodulator | Amlexanox 5% paste (not in U.S.) | Apply 4× daily |
SECOND-LINE
- Systemic corticosteroids (for major or refractory aphthae)
- Prednisone 0.75 mg/kg/day taper
- Montelukast 10 mg/day
- Colchicine, pentoxifylline, thalidomide, dapsone (caution: side effects)
- Levamisole (immune modulator)
- Penicillin G (short course)
REFERRALS
- Otolaryngology/dentist for persistent or unusual lesions
- Rheumatology/GI if suspect systemic disease
ADDITIONAL THERAPIES
- Vitamin B12 (1,000 mcg sublingual/day)
- Vitamin C (2,000 mg/day)
- H. pylori eradication (controversial)
- Low-level laser therapy (658 nm): may speed healing, reduce pain
FOLLOW-UP
- Monitor recurrence
- Reevaluate if nonhealing, new locations, or systemic features
- Educate on:
- SLS-free oral hygiene
- Avoid acidic, spicy, carbonated foods
- Nutrition and behavior modification
PROGNOSIS
- Most: self-limited, mild and recurrent
- Severe cases: potential for scarring, significant pain, and impaired QoL
- May improve with age
COMPLICATIONS
- Superinfection
- Scarring (especially in major aphthae)
- Functional impairment (e.g., eating, speaking)
- Psychosocial impact
CODES (ICD-10)
- K12.0 — Recurrent oral aphthae
CLINICAL PEARLS
- Most common ulcerative disease of the oral mucosa
- Painful ulcers on nonkeratinized mucosa = classic feature
- No HSV association with herpetiform ulcers
- Recurrent cases may require systemic workup
- SLS-free toothpaste, B12, and corticosteroids help in prevention and treatment